NCT01590407View on ClinicalTrials.gov

First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Hepatitis C, Chronic
Interventions
DRUG

ALS-002200

ALS-002200

DRUG

Placebo

Placebo

Trial Locations (4)

Unknown

Biotrial, Rennes

Biotrial, Paris

Arensia, Chisinau

Arensia, Bucharest

Sponsors
All Listed Sponsors
collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

Alios Biopharma Inc.

INDUSTRY

NCT01590407 - First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 | Biotech Hunter | Biotech Hunter